Tumour-associated peptides that bind to MHC molecules
AssigneeImmatics Biotechnologies GmbH
InventorsToni Weinschenk, Hans Georg Rammensee, Stefan Stevanovic
Life of this patent
Estimating the term…
Abstract
The invention relates to a tumor-associated peptide containing an amino sequence, which is selected from the group consisting of SEQ ID NO:1 to SEQ ID NO:79 of the enclosed listing. The peptide has the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I. The invention also relates to the use of the peptides for manufacture of a medicament and for treating tumorous diseases. The invention further relates to a pharmaceutical composition, which comprises at least one of the peptides.
Claims13
An isolated tumour-associated peptide comprising the amino acid sequence ALADGVQKV (SEQ ID NO:
- 77), the peptide having the ability to bind to a molecule of human major histocompatibility complex (MHC) class-I.
Dependencies are inferred from the claim text.